ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for alerts Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
Revolution Medicines Inc

Revolution Medicines Inc (RVMD)

43,93
-0,13
(-0,30%)
Beim Schlusskurs: 24 Dezember 10:00PM
43,93
0,00
( 0,00% )
Nach Börsenschluss: 12:00AM

Ihr Hub für Echtzeit-Streaming-Zitate, Ideen und Live-Diskussionen

Wichtige Statistiken und Details

Current Price
43,93
Gebot
43,00
Fragen
47,12
Volumen
757.722
43,13 Tagesbereich 44,17
25,93 52-Wochen-Bereich 62,40
Marktkapitalisierung
Handelsende
44,06
Handelsbeginn
43,61
Letzte Trade
1
@
44.81
Letzter Handelszeitpunkt
00:02:31
Finanzvolumen
US$ 33.163.257
VWAP
43,7671
Durchschnittliches Volumen (3 Mio.)
1.605.927
Ausgegebene Aktien
168.219.391
Dividendenrendite
-
Kurs-Gewinn-Verhältnis
-0,06
Gewinn pro Aktie (EPS)
-2,59
Erlöse
11,58M
Nettogewinn
-436,37M

Über Revolution Medicines Inc

Revolution Medicines Inc is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit elusive, frontier targets within notorious growth and survival pathways, with particular emphasis on the RAS and mTOR signaling pathways. The company's products include R... Revolution Medicines Inc is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit elusive, frontier targets within notorious growth and survival pathways, with particular emphasis on the RAS and mTOR signaling pathways. The company's products include RMC-4630, a SHP2 inhibitor, RAS(ON) portfolio, and SOS1 and 4EBP1/mTORC1 programs. Mehr anzeigen

Sektor
Biological Pds,ex Diagnstics
Branche
Biological Pds,ex Diagnstics
Website
Hauptsitz
Wilmington, Delaware, USA
Gegründet
-
Revolution Medicines Inc is listed in the Biological Pds,ex Diagnstics sector of the NASDAQ with ticker RVMD. The last closing price for Revolution Medicines was US$44,06. Over the last year, Revolution Medicines shares have traded in a share price range of US$ 25,93 to US$ 62,40.

Revolution Medicines currently has 168.219.391 shares in issue. The market capitalisation of Revolution Medicines is US$7,41 billion. Revolution Medicines has a price to earnings ratio (PE ratio) of -0.06.

RVMD Neueste Nachrichten

Revolution Medicines Announces Closing of Upsized Public Offering of Common Stock and Pre-Funded Warrants and Full Exercise of Underwriters' Option to Purchase Additional Shares

REDWOOD CITY, Calif., Dec. 05, 2024 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq: RVMD), a clinical-stage oncology company developing targeted therapies for patients with RAS-addicted...

Revolution Medicines Announces Pricing of Upsized $750.0 Million Public Offering of Common Stock and Pre-Funded Warrants

REDWOOD CITY, Calif., Dec. 03, 2024 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq: RVMD), a clinical-stage oncology company developing targeted therapies for patients with RAS-addicted...

Revolution Medicines Announces Commencement of Public Offering of Common Stock

REDWOOD CITY, Calif., Dec. 02, 2024 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq: RVMD), a clinical-stage oncology company developing targeted therapies for patients with RAS-addicted...

Revolution Medicines Provides Clinical Updates from its RAS(ON) Inhibitor Portfolio

Compelling Phase 1/1b update on RMC-6236 monotherapy in second-line metastatic pancreatic ductal adenocarcinoma supports ongoing Phase 3 RASolute 302 clinical trial Phase 1/1b proof-of-concept...

Revolution Medicines to Host RAS(ON) Inhibitor Clinical Update Webcast on December 2, 2024

REDWOOD CITY, Calif., Nov. 27, 2024 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq: RVMD), a clinical-stage oncology company developing targeted therapies for patients with RAS-addicted...

Revolution Medicines Reports Third Quarter 2024 Financial Results and Update on Corporate Progress

Phase 3 pivotal trial underway evaluating RMC-6236 in patients with metastatic pancreatic ductal adenocarcinoma (PDAC), supported by compelling clinical profile First clinical results for...

Revolution Medicines to Participate in Upcoming Investor Conferences

REDWOOD CITY, Calif., Nov. 05, 2024 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq: RVMD), a clinical-stage oncology company developing targeted therapies for RAS-addicted cancers, today...

Revolution Medicines to Report Financial Results for Third Quarter 2024 After Market Close on November 6, 2024

REDWOOD CITY, Calif., Oct. 30, 2024 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq: RVMD), a clinical-stage oncology company developing targeted therapies for patients with RAS-addicted...

Revolution Medicines Presents Initial Data from RMC-9805 Monotherapy Study in Patients with Advanced Pancreatic Ductal Adenocarcinoma

First clinical results for RMC-9805, a RAS(ON) G12D-selective inhibitor, demonstrate encouraging tolerability and antitumor activity in patients with PDAC Investor webcast to be held Friday...

Revolution Medicines Presents Updated Data from RMC-6236 Monotherapy Study in Patients with Advanced Pancreatic Ductal Adenocarcinoma

Encouraging progression-free survival and overall survival profile Safety findings consistent with previously reported data, no new safety signals observed Investor webcast to be held Friday...

Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
1-1.1-2.4428159005145.0346.1542.53171290444.00551666CS
4-13.84-23.957071144257.7759.7242.53221604448.30721574CS
12-0.1-0.22711787417744.0362.442.53160592750.85341231CS
265.514.311735623238.4362.436.5144976847.54949085CS
5216.2258.534824972927.7162.425.93139814640.80621561CS
15617.2764.778694673726.6662.414.08123633630.28178203CS
26014.5849.676320272629.3562.414.0894536330.96308063CS

RVMD - Frequently Asked Questions (FAQ)

What is the current Revolution Medicines share price?
The current share price of Revolution Medicines is US$ 43,93
How many Revolution Medicines shares are in issue?
Revolution Medicines has 168.219.391 shares in issue
What is the market cap of Revolution Medicines?
The market capitalisation of Revolution Medicines is USD 7,41B
What is the 1 year trading range for Revolution Medicines share price?
Revolution Medicines has traded in the range of US$ 25,93 to US$ 62,40 during the past year
What is the PE ratio of Revolution Medicines?
The price to earnings ratio of Revolution Medicines is -0,06
What is the cash to sales ratio of Revolution Medicines?
The cash to sales ratio of Revolution Medicines is 2,33
What is the reporting currency for Revolution Medicines?
Revolution Medicines reports financial results in USD
What is the latest annual turnover for Revolution Medicines?
The latest annual turnover of Revolution Medicines is USD 11,58M
What is the latest annual profit for Revolution Medicines?
The latest annual profit of Revolution Medicines is USD -436,37M
What is the registered address of Revolution Medicines?
The registered address for Revolution Medicines is 251 LITTLE FALLS DRIVE, WILMINGTON, DELAWARE, 19808
What is the Revolution Medicines website address?
The website address for Revolution Medicines is www.revmed.com
Which industry sector does Revolution Medicines operate in?
Revolution Medicines operates in the BIOLOGICAL PDS,EX DIAGNSTICS sector
  • Volumen
  • % Tops
  • % Flops
SymbolPreisVol.
CREVCarbon Revolution Public Ltd
US$ 9,093
(133,75%)
657,73k
NCRANocera Inc
US$ 1,42
(59,46%)
3,65M
BNOXBionomics Ltd
US$ 0,3751
(48,20%)
6,23M
MYNAMynaric AG
US$ 0,611
(38,98%)
6,82M
TIVCTivic Health Systems Inc
US$ 0,3101
(38,19%)
6,55M
SLGLSol Gel Technologies Ltd
US$ 1,05
(-36,36%)
3,58M
FRESFresh2 Group Ltd
US$ 0,68
(-20,00%)
71,33k
ANEBAnebulo Pharmaceuticals Inc
US$ 1,0201
(-18,39%)
2,65k
JZXNJiuzi Holdings Inc
US$ 1,45
(-12,12%)
312
TAOPTaoping Inc BVI
US$ 0,37
(-11,90%)
173,96k
TNXPTonix Pharmaceuticals Holding Corporation
US$ 0,4384
(8,76%)
13,84M
DRCTDirect Digital Holdings Inc
US$ 6,15
(11,82%)
12,1M
MYNAMynaric AG
US$ 0,611
(38,98%)
6,82M
TIVCTivic Health Systems Inc
US$ 0,3101
(38,19%)
6,55M
BNOXBionomics Ltd
US$ 0,3751
(48,20%)
6,23M
Keine Diskussionen Gefunden.
Neuen Thread Erstellen

Kürzlich von Ihnen besucht

Delayed Upgrade Clock